MichaelCharlesPrevitiMDRPNI

[Pronunciation: pra-veedy]

Hospital/Neurohospitalist, Vascular Neurology

Medical Director, Stroke Center at UW Valley Medical Center

Dr. Previti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of WashingtonFellowship, Vascular Neurology, 2012 - 2013
University of WashingtonResidency, Neurology, 2007 - 2010
University of WashingtonInternship, Internal Medicine, 2006 - 2007
University of Massachusetts Medical SchoolClass of 2006
University of PennsylvaniaBA, Biological Basis of Behavior, Cum Laude, 1996 - 2000

PubMed

63 citations
Regulation of the sodium iodide symporter by iodide in FRTL-5 cells.
Peter H. K. Eng, Guemalli R. Cardona, Michael C. Previti, William W. Chin, Lewis E. Braverman> ;European Journal of Endocrinology. 2001 Feb 1
255 citations
Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
Peter H. K. Eng, Guemalli R. Cardona, Shih-Lieh Fang, Michael C. Previti, Sharon Alex, Nancy Carrasco, William W. Chin, Lewis E. Braverman> ;Endocrinology. 1999 Aug 1
The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific.
Dotta F, Previti M, Neerman-Arbez M, Dionisi S, Cucinotta D, Lenti L, Di Mario U, Halban PA> ;Endocrinology. 1998-01-01
Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
Dotta F, Peterson LB, Previti M, Metzger J, Tiberti C, Anastasi E, Zoppitelli P, Wicker LS, Di Mario U> ;Endocrinology. 1992-01-01
Join now to see all

Books/Book Chapters

The Neurology of AIDS
Chapter: Spinal Cord Disease
Page 546 - 550Previti MC, Marra CMEditors: Gendelman HE, Grant I, Everall IP, Fox HS, Gelbard HA, Lipton SA, Swindells S.Oxford University Press, New YorkEdition 3rd,2012

Abstracts/Posters

LEV Monotherapy in Pts with Primary Brain Tumors: Efficacy, Side Effects, and CSF & Plasma Pharmacokinetics
Previti MC, Glanz, World Federation of Neuro-Oncology, Edinburgh, Scotland, 5/2005
Use of ZNS in Migraine Prophylaxis
Previti MC, Tosches W, American Headache Association Meeting, Vancouver, Canada, 6/2004
ZNS Monotherapy for Partial Seizures
Previti MC, Tosches W, American Epilepsy Society Meeting, Boston, MA, 12/2003

Lectures

From Symptom Onset to Drug: Current Practices and Future Ideas on How to Win the Race Against Time
University of Washington, Stroke Lecture Series - 5/29/2013